Iron status, hepcidin, and CRP in children with endoscopically confirmed adenotonsillar hypertrophy: a controlled

Serhan Keskin1, Nurşen Keskin2

  • 1Department of Otolaryngology, Head and Neck Surgery, Gebze Fatih State Hospital, Gebze, Kocaeli, Turkey. serhankeskin@live.com.

BMC Pediatrics
|May 29, 2026
PubMed

Insights

Adenotonsillar hypertrophy (ATH) in children does not significantly impact iron levels or inflammation markers. Routine iron evaluation is not recommended solely based on ATH, but targeted assessment may be useful for specific clinical signs.

Area of Science:

  • Pediatric Health
  • Hematology
  • Immunology

Background:

  • Adenotonsillar hypertrophy (ATH) may affect iron homeostasis and inflammation in children.
  • Previous findings on ATH's impact on iron status and inflammation in children are inconsistent.

Purpose of the Study:

  • To compare hematologic, iron-related, and inflammatory parameters in children with and without endoscopically confirmed ATH.
  • To investigate the association between ATH and iron deficiency, anemia, and inflammation markers.

Main Methods:

  • Controlled cross-sectional study of 300 children (6-12 years old): 150 with ATH, 150 controls.
  • Measured hemoglobin, serum iron, ferritin, mean corpuscular volume (MCV), C-reactive protein (CRP), and hepcidin.
  • Defined iron deficiency and anemia using World Health Organization criteria.

Main Results:

  • No statistically significant differences in hemoglobin, iron indices, CRP, or hepcidin between children with and without ATH.
  • Iron deficiency prevalence: 30% in ATH group vs. 24% in controls (p=0.24).
  • Iron-deficiency anemia prevalence: 10% in ATH group vs. 8% in controls (p=0.55).

Conclusions:

  • ATH is not associated with significant differences in routine iron indices, CRP, or hepcidin in this cohort.
  • Findings do not support routine iron evaluation solely based on ATH.
  • Targeted iron assessment may be considered for children with relevant clinical findings related to ATH.
Abstract

Related Concept Videos

Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.